Insulet | PODD - Market Capitalization


Insulet reported $10.64B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 181.89B 10.88B Oct/2026
Align Technology USD 11.47B 1.14B Oct/2026
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 12.63B 1.62B Oct/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Boston Scientific USD 62.54B 724M Oct/2026
Cardinal Health USD 55.64B 5.92B Jun/2026
Cooper Companies USD 14.1B 1.83B Jun/2026
Dexcom USD 30.98B 4.99B Oct/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Eli Lilly USD 1.3T 171.99B Oct/2026
Globus Medical USD 10.73B 963M Jun/2026
ICU Medical USD 3.66B 434M Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Integra LifeSciences USD 926M 340M Oct/2026
J&J USD 607B 46.61B Oct/2026
Medtronic USD 109.3B 2.33B Jun/2026
Merit Medical Systems USD 5.31B 1.17B Oct/2026
Roche Holding CHF 270B 3.66B Jun/2026
Stryker USD 118.41B 2.28B Oct/2026
Tandem Diabetes Care USD 1.03B 276M Jun/2026
Teleflex USD 6.43B 815M Oct/2026
West Pharmaceutical Services USD 31.25B 5.89B Oct/2026
WK Kellogg Co USD 13.36B 2.04B Jun/2026
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026